Literature DB >> 8539251

Stability of TEM beta-lactamase mutants hydrolyzing third generation cephalosporins.

X Raquet1, M Vanhove, J Lamotte-Brasseur, S Goussard, P Courvalin, J M Frère.   

Abstract

The stability properties of six natural mutants of the TEM-1 beta-lactamase have been studied. The glutamate to lysine substitution at positions 104 and 240 stabilize the enzyme. Conversely, the G238S mutant's decreased stability might reflect an altered conformation of the active site and thus be related to the modified substrate profile. The relative stability of the R164S and R164H mutants is explained by the formation of a hydrogen bond between these residues and Asp-179 conferring a somewhat different structure to the omega loop and thus also explaining the extended substrate profile of these mutants. The loss of stability of the R164H mutant with increasing pH values can be explained by the titration of a hydrogen bond between the N delta of His-164 and the O delta of Asp-179. The properties of the G238S + E104K double mutant which is the most active against third-generation cephalosporins result from a balance of destabilizing and stabilizing substitutions, and their effects seem to be additive. The behavior of the R164S + E240K mutant might be explained on the basis of a similar compensation phenomenon.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8539251     DOI: 10.1002/prot.340230108

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  21 in total

1.  A new TEM-derived extended-spectrum beta-lactamase (TEM-91) with an R164C substitution at the omega-loop confers ceftazidime resistance.

Authors:  Hiroshi Kurokawa; Naohiro Shibata; Yohei Doi; Keigo Shibayama; Kazunari Kamachi; Tetsuya Yagi; Yoshichika Arakawa
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

2.  Mistranslation drives the evolution of robustness in TEM-1 β-lactamase.

Authors:  Sinisa Bratulic; Florian Gerber; Andreas Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-21       Impact factor: 11.205

3.  Active TEM-1 beta-lactamase mutants with random peptides inserted in three contiguous surface loops.

Authors:  Pascale Mathonet; Julie Deherve; Patrice Soumillion; Jacques Fastrez
Journal:  Protein Sci       Date:  2006-09-08       Impact factor: 6.725

Review 4.  Catalytic properties of class A beta-lactamases: efficiency and diversity.

Authors:  A Matagne; J Lamotte-Brasseur; J M Frère
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

5.  Survey and molecular genetics of SHV beta-lactamases in Enterobacteriaceae in Switzerland: two novel enzymes, SHV-11 and SHV-12.

Authors:  M T Nüesch-Inderbinen; F H Kayser; H Hächler
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

6.  pKa calculations for class A beta-lactamases: methodological and mechanistic implications.

Authors:  X Raquet; V Lounnas; J Lamotte-Brasseur; J M Frère; R C Wade
Journal:  Biophys J       Date:  1997-11       Impact factor: 4.033

7.  Amino acid substitutions at Ambler position Gly238 in the SHV-1 beta-lactamase: exploring sequence requirements for resistance to penicillins and cephalosporins.

Authors:  Andrea M Hujer; Kristine M Hujer; Marion S Helfand; Vernon E Anderson; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

8.  Multiple global suppressors of protein stability defects facilitate the evolution of extended-spectrum TEM β-lactamases.

Authors:  Nicholas G Brown; Jeanine M Pennington; Wanzhi Huang; Tulin Ayvaz; Timothy Palzkill
Journal:  J Mol Biol       Date:  2010-10-16       Impact factor: 5.469

Review 9.  The continuing challenge of ESBLs.

Authors:  Federico Perez; Andrea Endimiani; Kristine M Hujer; Robert A Bonomo
Journal:  Curr Opin Pharmacol       Date:  2007-09-17       Impact factor: 5.547

10.  Crystal Structure of the Pseudomonas aeruginosa BEL-1 Extended-Spectrum β-Lactamase and Its Complexes with Moxalactam and Imipenem.

Authors:  Cecilia Pozzi; Filomena De Luca; Manuela Benvenuti; Laurent Poirel; Patrice Nordmann; Gian Maria Rossolini; Stefano Mangani; Jean-Denis Docquier
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.